Preben Haaning

Preben Haaning is a Senior Vice President at Novo Nordisk, overseeing the manufacturing and supply of biologics for rare blood and endocrine disorders. Preben has also served as a General Manager and Corporate Vice President, managing plant expansions and diabetes medication production. Additionally, Preben has experience in finance, logistics, IT, and industrial engineering. Preben currently serves as a Board Member at Xellia Pharmaceuticals and a Council Member at Novo Nordisk Haemophilia Foundation. Prior to their corporate roles, Preben worked as a Sales Representative, Platoon Leader for the United Nations, and First Lieutenant in the Danish Army. Preben holds degrees in Business Administration, Engineering, and Military leadership.